Neurocrine Biosciences, Inc. (NBIX)

128.14 -1.50 (-1.16%) USD  |  NASDAQ  |  Mar 06, 15:50
More

Neurocrine Biosciences EPS Diluted from Tax Loss Carryforward (Quarterly)

EPS Diluted from Tax Loss Carryforward (Quarterly) Chart

View EPS Diluted from Tax Loss Carryforward (Quarterly) for NBIX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted from Tax Loss Carryforward (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted from Tax Loss Carryforward (Quarterly) Range, Past 5 Years

View EPS Diluted from Tax Loss Carryforward (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted from Tax Loss Carryforward (Quarterly) Benchmarks

View EPS Diluted from Tax Loss Carryforward (Quarterly) Benchmarks
Start Trial
Glaukos Corp. --
Edgewise Therapeutics, Inc. --
Nuvalent, Inc. --
Marker Therapeutics, Inc. --
CapsoVision, Inc. --